Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on: December 26,2023

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on:December 26,2023

High magnetic field reduces side effects caused by anti-cancer drug imatinib

by Zhang Nannan,Chinese Academy of Sciences9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Credit: Ji XinmiaoResearchers led by Prof. Zhang Xin

Updated on: December 22,2023

High magnetic field reduces side effects caused by anti-cancer drug imatinib

by Zhang Nannan,Chinese Academy of Sciences9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice. Credit: Ji XinmiaoResearchers led by Prof. Zhang Xin

Updated on:December 22,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on: December 18,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on:December 18,2023

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

by Karolinska InstitutetCredit: CC0 Public DomainResearchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group,

Updated on: March 20,2024

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

by Karolinska InstitutetCredit: CC0 Public DomainResearchers at the Department of Medicine, Huddinge (MedH), Magnus Tobiasson and Eva Hellström-Lindberg have, together with the Nordic MDS group,

Updated on:March 20,2024

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

Updated on: July 09,2024

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

Updated on:July 09,2024

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on: December 02,2024

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on:December 02,2024

Regular exercise should be part of cancer care for all patients

byEuropean Society for Medical OncologyQuality of life scores before and after chemotherapy in active and inactive patients. Credit: European Society for Medical OncologyIncluding exercise or sp

Updated on: December 18,2023

Regular exercise should be part of cancer care for all patients

byEuropean Society for Medical OncologyQuality of life scores before and after chemotherapy in active and inactive patients. Credit: European Society for Medical OncologyIncluding exercise or sp

Updated on:December 18,2023

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainSurvivors of childhood cancer are at increased risk for cardiovascular disease, for which a risk factor is their greater preva

Updated on: April 27,2024

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainSurvivors of childhood cancer are at increased risk for cardiovascular disease, for which a risk factor is their greater preva

Updated on:April 27,2024

Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

byAmerican Cancer SocietyA new large study led by researchers at the American Cancer Societysuggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer

Updated on: August 27,2024

Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

byAmerican Cancer SocietyA new large study led by researchers at the American Cancer Societysuggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer

Updated on:August 27,2024

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on: May 31,2024

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on:May 31,2024

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

Updated on: December 27,2023

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

Updated on:December 27,2023